Pronethalol
Systematic (IUPAC) name | |
---|---|
1-(naphthalen-2-yl)-2-(propan-2-ylamino)ethanol | |
Clinical data | |
Legal status |
|
Routes of administration | Oral |
Identifiers | |
CAS Number | 51-02-5 |
ATC code | None |
PubChem | CID 4930 |
ChemSpider | 4761 |
UNII | XBP4RT1IMQ |
ChEMBL | CHEMBL16476 |
Chemical data | |
Formula | C15H19NO |
Molar mass | 229.32 g/mol |
Chirality | Racemic mixture |
|
Pronethalol (Alderlin, Nethalide) was an early non-selective beta blocker clinical candidate. It was never used clinically due to carcinogenicity in mice, which was thought to result from formation of a carcinogenic naphthalene epoxide metabolite.[1]
See also
References
|
This article is issued from Wikipedia - version of the Friday, February 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.